Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
32103 | 144 | 33.4 | 67% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
111 | 3 | THROMBOSIS RESEARCH//THROMBOSIS AND HAEMOSTASIS//HEMATOLOGY | 71244 |
1157 | 2 | FIBRINOLYSIS//PLASMINOGEN ACTIVATOR INHIBITOR 1//PAI 1 | 9477 |
32103 | 1 | CLIN BIOCHEM IMMUNOHEMATOL//INTERDISCIPLINARY EXCELLENCE PROGRAM HLTH AGI//NATURAL ANTIPLATELET AGENTS | 144 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | CLIN BIOCHEM IMMUNOHEMATOL | address | 900201 | 10% | 28% | 15 |
2 | INTERDISCIPLINARY EXCELLENCE PROGRAM HLTH AGI | address | 763372 | 8% | 30% | 12 |
3 | NATURAL ANTIPLATELET AGENTS | authKW | 424105 | 1% | 100% | 2 |
4 | SINTESIS | address | 424105 | 1% | 100% | 2 |
5 | ENGN BIOINFORMAT | address | 318076 | 2% | 50% | 3 |
6 | MED CORP JINKEIKAI | address | 282735 | 1% | 67% | 2 |
7 | NON ANTICOAGULATED BLOOD | authKW | 282735 | 1% | 67% | 2 |
8 | ABORAT COUNCIL SECRETARIAT | address | 212052 | 1% | 100% | 1 |
9 | BIOQUIM INMUNOHEMATOL CLIN | address | 212052 | 1% | 100% | 1 |
10 | C JUNS | authKW | 212052 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 1855 | 35% | 0% | 50 |
2 | Peripheral Vascular Diseases | 964 | 24% | 0% | 35 |
3 | Integrative & Complementary Medicine | 109 | 3% | 0% | 5 |
4 | Cardiac & Cardiovascular System | 57 | 9% | 0% | 13 |
5 | Nutrition & Dietetics | 51 | 6% | 0% | 8 |
6 | Endocrinology & Metabolism | 32 | 7% | 0% | 10 |
7 | Cell Biology | 27 | 9% | 0% | 13 |
8 | Medicine, General & Internal | 14 | 6% | 0% | 9 |
9 | Pathology | 14 | 3% | 0% | 5 |
10 | Cell & Tissue Engineering | 6 | 1% | 0% | 1 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLIN BIOCHEM IMMUNOHEMATOL | 900201 | 10% | 28% | 15 |
2 | INTERDISCIPLINARY EXCELLENCE PROGRAM HLTH AGI | 763372 | 8% | 30% | 12 |
3 | SINTESIS | 424105 | 1% | 100% | 2 |
4 | ENGN BIOINFORMAT | 318076 | 2% | 50% | 3 |
5 | MED CORP JINKEIKAI | 282735 | 1% | 67% | 2 |
6 | ABORAT COUNCIL SECRETARIAT | 212052 | 1% | 100% | 1 |
7 | BIOQUIM INMUNOHEMATOL CLIN | 212052 | 1% | 100% | 1 |
8 | CIBEROBENU CARLOS III | 212052 | 1% | 100% | 1 |
9 | IMMUNOHAEMATOL CLIN BIOCHEM | 212052 | 1% | 100% | 1 |
10 | INVEST CARDIOVASC ICCC CSIC | 212052 | 1% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PLATELETS | 12468 | 7% | 1% | 10 |
2 | PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS | 9391 | 3% | 1% | 4 |
3 | BLOOD COAGULATION & FIBRINOLYSIS | 7815 | 8% | 0% | 11 |
4 | NOUVELLE PRESSE MEDICALE | 5389 | 3% | 1% | 5 |
5 | THROMBOSIS RESEARCH | 2979 | 8% | 0% | 12 |
6 | EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE | 961 | 3% | 0% | 5 |
7 | ADVANCES IN CHILD DEVELOPMENT AND BEHAVIOR | 691 | 1% | 0% | 1 |
8 | HAEMOSTASIS | 683 | 1% | 0% | 2 |
9 | EXPERIMENTAL DIABETES RESEARCH | 669 | 1% | 0% | 1 |
10 | DIABETES | 629 | 4% | 0% | 6 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | NAEMURA, A , URA, M , YAMASHITA, T , ARAI, R , YAMAMOTO, J , (2008) LONG-TERM INTAKE OF ROSEMARY AND COMMON THYME HERBS INHIBITS EXPERIMENTAL THROMBOSIS WITHOUT PROLONGATION OF BLEEDING TIME.THROMBOSIS RESEARCH. VOL. 122. ISSUE 4. P. 517-522 | 18 | 82% | 6 |
2 | YAMAMOTO, J , YAMADA, K , NAEMURA, A , YAMASHITA, T , ARAI, R , (2005) TESTING VARIOUS HERBS FOR ANTITHROMBOTIC EFFECT.NUTRITION. VOL. 21. ISSUE 5. P. 580-587 | 13 | 46% | 25 |
3 | NAEMURA, A , MITANI, T , IJIRI, Y , TAMURA, Y , YAMASHITA, T , OKIMURA, M , YAMAMOTO, J , (2005) ANTI-THROMBOTIC EFFECT OF STRAWBERRIES.BLOOD COAGULATION & FIBRINOLYSIS. VOL. 16. ISSUE 7. P. 501-509 | 14 | 39% | 23 |
4 | KOYAMA, A , KURIOKA, A , YAMASHITA, T , IJIRI, Y , URA, M , NAEMURA, A , YAMAMOTO, J , (2006) TESTING VARIOUS FRUITS FOR ANTI-THROMBOTIC EFFECT: I. MULBERRIES.PLATELETS. VOL. 17. ISSUE 8. P. 555-564 | 14 | 38% | 9 |
5 | IJIRI, Y , NAEMURA, A , YAMASHITA, T , IKARUGI, H , MEGURO, S , TOKIMITSU, I , YAMAMOTO, J , (2006) MECHANISM OF THE ANTITHROMBOTIC EFFECT OF DIETARY DIACYLGLYCEROL IN ATHEROGENIC MICE.PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS. VOL. 35. ISSUE 5. P. 380 -387 | 15 | 33% | 2 |
6 | YAMAMOTO, J , NAEMURA, A , IJIRI, Y , OGAWA, K , SUZUKI, T , SHIMADA, Y , GIDDINGS, JC , (2008) THE ANTITHROMBOTIC EFFECTS OF CARROT FILTRATES IN RATS AND MICE.BLOOD COAGULATION & FIBRINOLYSIS. VOL. 19. ISSUE 8. P. 785-792 | 10 | 43% | 2 |
7 | FUENTES, E , PEREIRA, J , ALARCON, M , VALENZUELA, C , PEREZ, P , ASTUDILLO, L , PALOMO, I , (2013) PROTECTIVE MECHANISMS OF S. LYCOPERSICUM AQUEOUS FRACTION (NUCLEOSIDES AND FLAVONOIDS) ON PLATELET ACTIVATION AND THROMBUS FORMATION: IN VITRO, EX VIVO AND IN VIVO STUDIES.EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE. VOL. . ISSUE . P. - | 13 | 30% | 0 |
8 | ALARCON, M , FUENTES, E , OLATE, N , NAVARRETE, S , CARRASCO, G , PALOMO, I , (2015) STRAWBERRY EXTRACT PRESENTS ANTIPLATELET ACTIVITY BY INHIBITION OF INFLAMMATORY MEDIATOR OF ATHEROSCLEROSIS (SP-SELECTIN, SCD40L, RANTES, AND IL-1 BETA) AND THROMBUS FORMATION.PLATELETS. VOL. 26. ISSUE 3. P. 224 -229 | 10 | 29% | 6 |
9 | NAEMURA, A , OHIRA, H , IKEDA, M , KOSHIKAWA, K , ISHII, H , YAMAMOTO, J , (2006) AN EXPERIMENTALLY ANTITHROMBOTIC STRAWBERRY VARIETY IS ALSO EFFECTIVE IN HUMANS.PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS. VOL. 35. ISSUE 5. P. 398-404 | 8 | 40% | 4 |
10 | NAEMURA, A , IJIRI, Y , KODAMA, M , HONDA, Y , YAMAMOTO, J , (2007) A RICE VARIETY (HYJA-RI4) ENHANCES ARTERIAL THROMBUS FORMATION IN AN ANIMAL MODEL OF THROMBOSIS.PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS. VOL. 36. ISSUE 5. P. 241-244 | 8 | 33% | 0 |
Classes with closest relation at Level 1 |